[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO20071458L - Nanopartikkel og fremgangsmate for fremstilling av denne - Google Patents

Nanopartikkel og fremgangsmate for fremstilling av denne

Info

Publication number
NO20071458L
NO20071458L NO20071458A NO20071458A NO20071458L NO 20071458 L NO20071458 L NO 20071458L NO 20071458 A NO20071458 A NO 20071458A NO 20071458 A NO20071458 A NO 20071458A NO 20071458 L NO20071458 L NO 20071458L
Authority
NO
Norway
Prior art keywords
gelatin
preparation
nanoparticle
maximum
nanoparticles
Prior art date
Application number
NO20071458A
Other languages
English (en)
Norwegian (no)
Inventor
Michael Ahlers
Conrad Coester
Klaus Zwiorek
Jan Zillies
Original Assignee
Gelita Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gelita Ag filed Critical Gelita Ag
Publication of NO20071458L publication Critical patent/NO20071458L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5169—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Jellies, Jams, And Syrups (AREA)
NO20071458A 2004-08-20 2007-03-19 Nanopartikkel og fremgangsmate for fremstilling av denne NO20071458L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004041340A DE102004041340A1 (de) 2004-08-20 2004-08-20 Nanopartikel und Verfahren zu deren Herstellung
PCT/EP2005/008954 WO2006021367A1 (de) 2004-08-20 2005-08-18 Nanopartikel und verfahren zu deren herstellung

Publications (1)

Publication Number Publication Date
NO20071458L true NO20071458L (no) 2007-03-19

Family

ID=35276582

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20071458A NO20071458L (no) 2004-08-20 2007-03-19 Nanopartikkel og fremgangsmate for fremstilling av denne

Country Status (14)

Country Link
US (1) US20080003292A1 (de)
EP (1) EP1793810A1 (de)
JP (1) JP2008510688A (de)
KR (1) KR20070046850A (de)
CN (1) CN1988892A (de)
AU (1) AU2005276675A1 (de)
BR (1) BRPI0514524A (de)
CA (1) CA2575407A1 (de)
DE (1) DE102004041340A1 (de)
IL (1) IL180954A0 (de)
MX (1) MX2007001996A (de)
NO (1) NO20071458L (de)
NZ (1) NZ551326A (de)
WO (1) WO2006021367A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2451523C2 (ru) 2005-12-14 2012-05-27 Цитос Биотехнологи Аг Упакованные иммуностимулирующей нуклеиновой кислотой частицы, предназначенные для лечения гиперчувствительности
WO2007072982A1 (en) * 2005-12-20 2007-06-28 Fujifilm Corporation Protein nanoparticles and the use of the same
JP2007224012A (ja) * 2006-01-30 2007-09-06 Fujifilm Corp 酵素架橋したタンパク質ナノ粒子
WO2007144150A1 (en) 2006-06-12 2007-12-21 Cytos Biotechnology Ag Processes for packaging oligonucleotides into virus-like particles of rna bacteriophages
JP2008001764A (ja) * 2006-06-21 2008-01-10 Gunma Univ タンパク質からなる粒子状成形体の製造方法及び、該方法により得られたタンパク質からなる粒子状成形体
JP5275561B2 (ja) * 2006-10-30 2013-08-28 富士フイルム株式会社 水分散可能なナノ粒子
DE602007002784D1 (de) * 2007-03-16 2009-11-26 Univ Nat Chi Nan Bioabbaubares Material mit Nanoporen und elektrischer Leitfähigkeit sowie Herstellungsverfahren dafür
JP2008260705A (ja) * 2007-04-11 2008-10-30 Fujifilm Corp 注射用組成物
JP2008297241A (ja) * 2007-05-31 2008-12-11 Fujifilm Corp ニキビ用皮膚外用剤
DE102007041625A1 (de) * 2007-09-03 2009-03-05 Sinn, Hannsjörg, Dr. Neue Gelatine-Wirkstoff-Konjugate
AU2011326767B2 (en) 2010-11-10 2016-02-11 Prokidney Injectable formulations for organ augmentation
EP2540287A1 (de) 2011-07-01 2013-01-02 FutureChemistry Fließfertigung von Gelatine-Nanoteilchen
DE102011052396A1 (de) * 2011-08-04 2013-02-07 Gelita Ag Verfahren zur Herstellung einer stabilen Dispersion von Nanopartikeln, hergestellte Dispersion und deren Verwendung
JP6851987B2 (ja) * 2015-12-25 2021-03-31 コニカミノルタ株式会社 ゼラチン粒子、ゼラチン粒子の製造方法、ゼラチン粒子内包細胞、およびゼラチン粒子内包細胞の製造方法
CA3010995A1 (en) 2016-01-25 2017-08-03 Suntory Holdings Limited Capsule containing functional substance and method for manufacturing said capsule
CN107376008B (zh) 2017-07-21 2019-10-22 深圳华诺生物科技有限公司 一种无机纳米颗粒-明胶核壳结构复合材料颗粒的制备方法
WO2021132741A1 (ko) * 2019-12-23 2021-07-01 주식회사 피엘마이크로메드 색전 시술 입자 및 이의 제조방법
KR102386631B1 (ko) * 2020-04-09 2022-04-15 주식회사 피엘마이크로메드 색전 시술용 마이크로 비드 및 증식성 질환 치료용 조성물
WO2021206440A1 (ko) * 2020-04-09 2021-10-14 주식회사 피엘마이크로메드 색전 시술용 마이크로 비드 및 증식성 질환 치료용 조성물
KR102645182B1 (ko) * 2021-08-23 2024-03-07 전남대학교산학협력단 젤라틴 가교입자의 제조 방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4107288A (en) * 1974-09-18 1978-08-15 Pharmaceutical Society Of Victoria Injectable compositions, nanoparticles useful therein, and process of manufacturing same
DE4140183C2 (de) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Retardform für ein Flurbiprofen enthaltendes Arzneimittel
US5932245A (en) * 1991-12-05 1999-08-03 Alfatec Pharma Gmbh Gelatin or collagen hydrolysate containing drug formulation that provides for immediate release of nanoparticle drug compounds
DE4140185C2 (de) * 1991-12-05 1996-02-01 Alfatec Pharma Gmbh Ein 2-Arylpropionsäurederivat in Nanosolform enthaltendes Arzneimittel und seine Herstellung
DE4140195C2 (de) * 1991-12-05 1994-10-27 Alfatec Pharma Gmbh Pharmazeutisch applizierbares Nanosol und Verfahren zu seiner Herstellung
DE19838189A1 (de) * 1998-08-24 2000-03-02 Basf Ag Stabile pulverförmige Vitamin- und Carotinoid-Zubereitungen und Verfahren zu deren Herstellung
WO2000059538A2 (en) * 1999-04-08 2000-10-12 The John Hopkins University Antigen-specific induction of peripheral immune tolerance
ATE487470T1 (de) * 2002-09-11 2010-11-15 Elan Pharma Int Ltd Gel-stabilisierte wirkstoff-zusammensetzungen in nanoteilchengrösse
CA2435632A1 (en) * 2003-07-21 2005-01-21 Warren Hugh Finlay Formulation of powder containing nanoparticles for aerosol delivery to the lung

Also Published As

Publication number Publication date
DE102004041340A1 (de) 2006-02-23
US20080003292A1 (en) 2008-01-03
WO2006021367A1 (de) 2006-03-02
CA2575407A1 (en) 2006-03-02
MX2007001996A (es) 2007-05-10
JP2008510688A (ja) 2008-04-10
NZ551326A (en) 2010-04-30
KR20070046850A (ko) 2007-05-03
EP1793810A1 (de) 2007-06-13
AU2005276675A1 (en) 2006-03-02
CN1988892A (zh) 2007-06-27
BRPI0514524A (pt) 2008-06-10
IL180954A0 (en) 2007-07-04

Similar Documents

Publication Publication Date Title
NO20071458L (no) Nanopartikkel og fremgangsmate for fremstilling av denne
Peng et al. Simple aqueous solution route to luminescent carbogenic dots from carbohydrates
WO2007077399A3 (fr) Gel viscoelastique a usage dermatologique
NO20071974L (no) Blodplate-avledet vekstfaktor sammensetning og fremgangsmater for anvendelse derav
BR0305916A (pt) Dispersão, composição cosmética ou farmacêutica e processo para tratamento cosmético
RS51185B (sr) Kompozicije za vaginalnu primenu
WO2008129106A3 (es) Nanopartículas que comprenden una ciclodextrina y una molécula biológicamente activa y sus aplicaciones
DE50307767D1 (de) Kosmetische zubereitung
DE602005015704D1 (de) Flüssige dispersionspolymerzusammensetzungen, ihre herstellung und ihre verwendung
CO5540367A2 (es) Composicion de liberacion controlada y metodo para producirla
Li et al. Carbon dot/poly (methylacrylic acid) nanocomposite hydrogels with high toughness and strong fluorescence
ATE539175T1 (de) Schmiedestahl und geschmiedete produkte, die daraus erhalten werden können
BR0311700A (pt) Processo para a produção de uma preparação em forma de pelìcula e preparação em forma de pelìcula
Li et al. Photocontrollable water-soluble polymeric hydrogen sulfide (H2S) donor
WO2008067436A3 (en) Compounds and formulations suitable for radical scavenging
WO2011005666A3 (en) Methods for treating hydrocarbon-bearing formations with fluorinated acid compositions
Bao et al. Self‐assembly of a renewable lignin biopolymer in nanoparticles with multiple morphologies
Yong et al. The unexplored potential of gas‐responsive polymers in drug delivery: progress, challenges and outlook
ATE514746T1 (de) Kohlenstoffnanoröhrchen verstärkte polymerzusammensetzung und verfahren zu deren herstellung
WO2004089992A8 (ja) 改質アラビアガムおよびその用途
CN103911680A (zh) 一种复合胶原纤维及其制备方法
NO20050247L (no) Lavmolekylaert oversulfatert polysakkarid
WO2008102144A3 (en) Aqueous formulations
Arnold et al. Functional graphenic materials that seal condenser tube leaks in situ
Gan et al. Preparation and physicochemical properties of coenzyme Q10 loaded niosomal hydrogels based on carbomer and scleroglucan

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application